-
Something wrong with this record ?
Reference values of parathyroid hormone in very low birth weight infants
T. Matejek, B. Zapletalova, J. Stranik, L. Zaloudkova, V. Palicka
Language English Country England, Great Britain
Document type Journal Article
- MeSH
- Alkaline Phosphatase blood MeSH
- Phosphorus blood urine MeSH
- Creatinine blood urine MeSH
- Humans MeSH
- Infant, Very Low Birth Weight * blood urine MeSH
- Infant, Newborn MeSH
- Parathyroid Hormone * blood MeSH
- Reference Values MeSH
- Calcium * blood urine MeSH
- Vitamin D blood analogs & derivatives MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Infant, Newborn MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
PURPOSE: The primary goal was to estimate reference values of parathyroid hormone (PTH) in very low birth weight infants without severe neonatal morbidity. A secondary objective was to assess the relationship between PTH serum levels and selected laboratory markers of bone metabolism. METHODS: Ninety two infants with birth weight less than 1500 g met the inclusion criteria of the study. Serum levels of PTH, 25-hydroxyvitamin-D [25(OH)D], C3-epi-25(OH)D, total calcium, phosphorus, and alkaline phosphatase, and urinary levels of calcium, phosphorus, and creatinine were examined on day 14 and subsequently every 2 weeks until discharge. RESULTS: Of the total 167 serum samples examined for PTH levels in infants without 25(OH)D deficiency the estimated range was 0.9-11.9 pmol/l (8.5-112.3 pg/mL). During the first month, no statistically significant correlation was observed between PTH level and that of 25(OH)D, C3-epimers of 25(OH)D, S-Ca, S-P, or ALP, nor with urinary excretion of calcium and phosphorus. From the second month of life, there was a moderately significant correlation between PTH and 25(OH)D (Rho = -0.40, P =< .001), between PTH and calcium/creatinine ratio (Rho = -0.56, P = < .001), and between PTH and phosphorus/creatinine ratio (Rho = 0.51, P = < .001). CONCLUSIONS: The physiological range for PTH levels for preterm neonates without 25(OH)D deficiency was estimated as 0.9-11.9 pmol/l (8.5-112.3 pg/mL). It seems that elevation of serum PTH above this range can be considered as hyperparathyroidism in very low birth weight infants.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019203
- 003
- CZ-PrNML
- 005
- 20241024111424.0
- 007
- ta
- 008
- 241015s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1177/00045632241245942 $2 doi
- 035 __
- $a (PubMed)38520177
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Matejek, Tomas $u Department of Paediatrics, Charles University in Prague, Faculty of Medicine Hradec Kralove, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic $1 https://orcid.org/0000000273599670
- 245 10
- $a Reference values of parathyroid hormone in very low birth weight infants / $c T. Matejek, B. Zapletalova, J. Stranik, L. Zaloudkova, V. Palicka
- 520 9_
- $a PURPOSE: The primary goal was to estimate reference values of parathyroid hormone (PTH) in very low birth weight infants without severe neonatal morbidity. A secondary objective was to assess the relationship between PTH serum levels and selected laboratory markers of bone metabolism. METHODS: Ninety two infants with birth weight less than 1500 g met the inclusion criteria of the study. Serum levels of PTH, 25-hydroxyvitamin-D [25(OH)D], C3-epi-25(OH)D, total calcium, phosphorus, and alkaline phosphatase, and urinary levels of calcium, phosphorus, and creatinine were examined on day 14 and subsequently every 2 weeks until discharge. RESULTS: Of the total 167 serum samples examined for PTH levels in infants without 25(OH)D deficiency the estimated range was 0.9-11.9 pmol/l (8.5-112.3 pg/mL). During the first month, no statistically significant correlation was observed between PTH level and that of 25(OH)D, C3-epimers of 25(OH)D, S-Ca, S-P, or ALP, nor with urinary excretion of calcium and phosphorus. From the second month of life, there was a moderately significant correlation between PTH and 25(OH)D (Rho = -0.40, P =< .001), between PTH and calcium/creatinine ratio (Rho = -0.56, P = < .001), and between PTH and phosphorus/creatinine ratio (Rho = 0.51, P = < .001). CONCLUSIONS: The physiological range for PTH levels for preterm neonates without 25(OH)D deficiency was estimated as 0.9-11.9 pmol/l (8.5-112.3 pg/mL). It seems that elevation of serum PTH above this range can be considered as hyperparathyroidism in very low birth weight infants.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a parathormon $x krev $7 D010281
- 650 12
- $a novorozenec s velmi nízkou porodní hmotností $x krev $x moč $7 D019102
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a referenční hodnoty $7 D012016
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a vápník $x krev $x moč $7 D002118
- 650 _2
- $a fosfor $x krev $x moč $7 D010758
- 650 _2
- $a vitamin D $x krev $x analogy a deriváty $7 D014807
- 650 _2
- $a alkalická fosfatasa $x krev $7 D000469
- 650 _2
- $a kreatinin $x krev $x moč $7 D003404
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Zapletalova, Bara $u Department of Paediatrics, Charles University in Prague, Faculty of Medicine Hradec Kralove, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Stranik, Jaroslav $u Department of Obstetrics and Gynecology, Charles University in Prague, Faculty of Medicine Hradec Kralove, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Zaloudkova, Lenka $u Institute of Clinical Biochemistry and Diagnostics, Faculty of Medicine Hradec Kralove, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Palicka, Vladimir $u Institute of Clinical Biochemistry and Diagnostics, Faculty of Medicine Hradec Kralove, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
- 773 0_
- $w MED00000421 $t Annals of clinical biochemistry $x 1758-1001 $g Roč. 61, č. 5 (2024), s. 372-385
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38520177 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111418 $b ABA008
- 999 __
- $a ok $b bmc $g 2201819 $s 1231176
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 61 $c 5 $d 372-385 $e 20240406 $i 1758-1001 $m Annals of clinical biochemistry $n Ann Clin Biochem $x MED00000421
- LZP __
- $a Pubmed-20241015
